EUIPO trademark

DBV Technologies design mark 019230243

RegisteredEUIPOFigurative markClass 5Class 10Class 41Class 42+1

"Design mark 019230243" is a figurative mark owned by DBV Technologies, filed at the EUIPO on August 8, 2025. It is registered and covers classes 5, 10, 41, 42 and 44.

Official EUIPO record
DBV Technologies design mark 019230243 trademark as filed
As filed with the EUIPO
Status
Registered
Since February 9, 2026
Filed
August 8, 2025
Registered
February 6, 2026
Expires
August 8, 2035
Application no.
019230243
Registration no.
019230243
Office
EUIPO
European Union Intellectual Property Office
Mark type
Figurative mark
5 classes
Ownership

Who owns DBV Technologies design mark 019230243

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services DBV Technologies design mark 019230243 is filed for, grouped by Nice class.

  • Transdermal patches; skin patches and adhesive skin patches for medical use; transdermal and adhesive skin patches for treating, alleviating or preventing the development or progression of allergies or immunological disorders; transdermal and adhesive skin patches for the transdermal delivery of pharmaceuticals or medical preparations; patches or epicutaneous systems for the cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; adhesive patches or adhesive epicutaneous systems for cutaneous or epicutaneous administration of medical or pharmaceutical substances for treating allergies or immunological disorders; occlusive patches or occlusive epicutaneous systems for cutaneous or epicutaneous administration of powdered medical or pharmaceutical substances for treating allergies or immunological disorders; patches or epicutaneous systems containing a powdered preparation for medical or pharmaceutical use for treating allergies or immunological disorders; patches or epicutaneous systems for use in the treatment of allergies or immunological disorders; patches or epicutaneous systems featuring allergens or antigens for treating allergies or immunological disorders; allergy medication; pharmaceutical preparations for treating allergies; pharmaceutical preparations for treating food allergies; pads and skin patches for receiving, holding or containing medical or pharmaceutical substances for the treatment, alleviation or prevention of allergies or immunological disorders; parts and fittings for all the aforesaid goods

  • Medical instruments, apparatus and devices for the cutaneous, epicutaneous or patch-based administration or delivery of medical or pharmaceutical substances for the treatment, alleviation or prevention of allergies or immunological disorders; pads and skin patches for medical training purposes; pads and skin patches for medical use, namely for use in training medical professionals on the transdermal delivery of pharmaceuticals or medical preparations; medical instruments, apparatus and devices sold without medication for the later administration, by cutaneous or epicutaneous means, of medical or pharmaceutical substances; pad, skin patch and occlusion patch dispensers and applicators for medical use; parts and fittings for all the aforesaid goods

  • Educational and training services for consumers and medical professionals in the field of allergies and immunotherapy; provision of classes, seminars, programmes, conferences, congresses and workshops in the field of allergies and immunotherapy; organizing and providing exhibitions for online educational purposes featuring interactive presentations and exhibitions in the field of allergies and immunotherapy; publication of periodicals, books, guides and databases in the field of allergies and immunotherapy; information, advisory and consultancy services relating to all of the aforesaid

  • Medical and scientific research in the fields of allergies and immunotherapy; development of scientific methods for cutaneous and epicutaneous immunotherapy; medical and scientific research relating to the treatment, alleviation and prevention of autoimmune, infectious and inflammatory diseases; medical and scientific research in the fields of allergy treatment and care; allergenic drug discovery services; medical and scientific research services, namely, developing methods for treating allergies via contact between allergens and the skin; medical and scientific research services, namely, developing methods for the treatment and prevention of allergies, autoimmune, infectious and inflammatory diseases by applying patches to patients' skin; information, advisory and consultancy services relating to all of the aforesaid

  • Medical services relating to the treatment, alleviation and prevention of allergies; medical treatment, alleviation and prevention of allergies, inflammatory, autoimmune and infectious diseases through the administration of medical or pharmaceutical substances, allergens or antigens using patches affixed to patients' skin; medical consultancy in the field of desensitization to allergies; information, advisory and consultancy services relating to all of the aforesaid

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2026/025 Section B.1
  2. Bulletin 2025/204 Section A.1
FAQ

About DBV Technologies design mark 019230243

Who owns the trademark "Design mark 019230243"?

The EUIPO trademark "Design mark 019230243" (application 019230243) is owned by DBV Technologies.

What is the status of "Design mark 019230243"?

Its status at the EUIPO is: registered.

When was "Design mark 019230243" registered?

It was registered on February 6, 2026 and is due to expire on August 8, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DBV Technologies design mark 019230243 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d48b3-fe02-777d-8b25-ee11ba7662de
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d48b3-fe02-777d-8b25-ee11ba7662de",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019230243",
  "filing_date": "2025-08-08",
  "nice_classes": [
    5,
    10,
    41,
    42,
    44
  ],
  "owners": [
    {
      "name": "DBV Technologies",
      "entity_id": "ent_019eb706-d4df-739e-ba1d-b3581088cd30"
    }
  ]
}